Celldex Therapeutics, Inc. - 8-K Filing
Celldex Therapeutics CFO Sam Martin to retire in March 2027; company begins search for replacement (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)
Tickers: $CLDX